Safe-by-design Report finalized
Roll-to-roll Pilot imprinting of Neuron drug-screening devices DEM2 (100 m² of foil)
Roll-to-roll Pilot imprinting of Point of care diagnostic devices DEM1 (100 m² of foil)
Fully functional Demonstrator 2 Test Chips. Backend processing is still done in Batch.
DEM1 chips with R2R top and bottom foil. Backend processing is still performed in Batch.
DEM1 chips with improved optical collection efficiency (imprinted optical micro/nanostructures)
Fully functional DEM1 chips for MRSA detection assembled of R2R fabricated components. Backend processing is still performed in Batch.
Demonstrator 2 Chips based on radial design (according to Gen .2)
Operational ready roll-to-roll Pilot manufacturing line
Autorzy: P. Toren, M. Rumpler, M. Smolka, A. Haase, S. Ruttloff, D. Nees, B. Stadlober, I. Katzmayr, B. Hierschlager, S. Kierstein, M. Sonnleitner, G. Bared, M. Horn, W. Weigel, J. Hesse
Opublikowane w: European Journal of Materials Science and Engineering, 2019, ISSN 2537-4346
Wydawca: Str. Prof.dr.doc. D. Mangeron